High resolution of heterochromatin of Drosophila melanogaster by distamycin A.
A DNA-binding AT-specific antibiotic, distamycin A, was used as inhibitor of the condensation process of the heterochromatic regions in Drosophila melanogaster embryonic cells. By this treatment the structural organization of heterochromatin at interphase is preserved until metaphase. The different patterns observed are interpreted as chronological steps in the condensation process.
D000818:Animals; D004214:Distamycins / Q000494:pharmacology*; D004331:Drosophila melanogaster / Q000196:embryology; D006570:Heterochromatin / Q000187:drug effects / Q000648:ultrastructure*; D007399:Interphase / Q000187:drug effects; D008297:Male; D008677:Metaphase / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology*
D004214:Distamycins; D006570:Heterochromatin; D011758:Pyrroles; C030000:stallimycin